These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 21269506

  • 1. Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions.
    Reichart DL, Hinkle RT, Lefever FR, Dolan ET, Dietrich JA, Sibley DR, Isfort RJ.
    BMC Musculoskelet Disord; 2011 Jan 26; 12():27. PubMed ID: 21269506
    [Abstract] [Full Text] [Related]

  • 2. Corticotropin releasing factor 2 receptor agonists reduce the denervation-induced loss of rat skeletal muscle mass and force and increase non-atrophying skeletal muscle mass and force.
    Hinkle RT, Donnelly E, Cody DB, Bauer MB, Sheldon RJ, Isfort RJ.
    J Muscle Res Cell Motil; 2004 Jan 26; 25(7):539-47. PubMed ID: 15711884
    [Abstract] [Full Text] [Related]

  • 3. Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals.
    Hinkle RT, Lefever FR, Dolan ET, Reichart DL, Zwolshen JM, Oneill TP, Maloney KG, Mattson JP, Ferreira LF, Musch TI, Poole DC, Isfort RJ.
    BMC Musculoskelet Disord; 2011 Jan 14; 12():15. PubMed ID: 21235761
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involvement of cAMP/EPAC/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats.
    Arcaro CA, Assis RP, Zanon NM, Paula-Gomes S, Navegantes LCC, Kettelhut IC, Brunetti IL, Baviera AM.
    J Appl Physiol (1985); 2018 Mar 01; 124(3):704-716. PubMed ID: 29357512
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL, Free RB, Sibley DR.
    ACS Chem Neurosci; 2015 Apr 15; 6(4):681-92. PubMed ID: 25660762
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Balanced Diet-Fed Fat-1 Transgenic Mice Exhibit Lower Hindlimb Suspension-Induced Soleus Muscle Atrophy.
    Marzuca-Nassr GN, Murata GM, Martins AR, Vitzel KF, Crisma AR, Torres RP, Mancini-Filho J, Kang JX, Curi R.
    Nutrients; 2017 Oct 06; 9(10):. PubMed ID: 28984836
    [Abstract] [Full Text] [Related]

  • 15. The effect of creatine supplementation on mass and performance of rat skeletal muscle.
    Young RE, Young JC.
    Life Sci; 2007 Aug 09; 81(9):710-6. PubMed ID: 17707068
    [Abstract] [Full Text] [Related]

  • 16. Myostatin dysfunction does not protect from fasting-induced loss of muscle mass in mice.
    Fokin A, Minderis P, Venckunas T, Lionikas A, Kvedaras M, Ratkevicius A.
    J Musculoskelet Neuronal Interact; 2019 Sep 01; 19(3):342-353. PubMed ID: 31475942
    [Abstract] [Full Text] [Related]

  • 17. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model.
    Nguyen T, Bowen TS, Augstein A, Schauer A, Gasch A, Linke A, Labeit S, Adams V.
    Skelet Muscle; 2020 Apr 27; 10(1):12. PubMed ID: 32340625
    [Abstract] [Full Text] [Related]

  • 18. Effects of pleiotrophin overexpression on mouse skeletal muscles in normal loading and in actual and simulated microgravity.
    Camerino GM, Pierno S, Liantonio A, De Bellis M, Cannone M, Sblendorio V, Conte E, Mele A, Tricarico D, Tavella S, Ruggiu A, Cancedda R, Ohira Y, Danieli-Betto D, Ciciliot S, Germinario E, Sandonà D, Betto R, Camerino DC, Desaphy JF.
    PLoS One; 2013 Apr 27; 8(8):e72028. PubMed ID: 24015201
    [Abstract] [Full Text] [Related]

  • 19. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT, Chee A, Gleeson BG, Naim T, Swiderski K, Koopman R, Lynch GS.
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep 27; 301(3):R716-26. PubMed ID: 21677277
    [Abstract] [Full Text] [Related]

  • 20. Oral fucoidan improves muscle size and strength in mice.
    McBean SE, Church JE, Thompson BK, Taylor CJ, Fitton JH, Stringer DN, Karpiniec SS, Park AY, van der Poel C.
    Physiol Rep; 2021 Feb 27; 9(3):e14730. PubMed ID: 33527754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.